Meanwhile, lack of response is related to a signature of TGF-β1 signaling effectors in fibroblasts, especially in individuals with tumors with CD8+ T cells excluded from the tumor parenchyma and instead located in the peritumoral stroma [17]. The gene discussed is TGFB1; the disease is neoplasm.